Development of Nanostructured Lipid Carriers Containing Finasteride
January 2020
in “
Brazilian Journal of Health and Pharmacy
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This study developed nanostructured lipid carriers for finasteride that demonstrated high encapsulation efficiency and reduced cytotoxicity, suggesting potential as a topical treatment for androgenetic alopecia.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study focused on developing nanostructured lipid carriers (NLCs) containing finasteride to enhance its delivery and efficacy in treating hair loss. The researchers formulated and characterized the NLCs, assessing parameters such as particle size, zeta potential, and drug encapsulation efficiency. The optimized NLCs showed improved stability and controlled release properties, suggesting that NLCs could be a promising vehicle for finasteride in the treatment of alopecia.
